Alembic Pharmaceuticals gets EIR from USFDA for Panelav facility

05 Oct 2016 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA). The regulator had carried out the inspection at the company's formulation facility located at Panelav in March, 2016.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

1055.00 0.00 (0.00%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1809.15
Dr. Reddys Lab 1369.15
Cipla 1471.95
Lupin 2151.60
Zydus Lifesciences 972.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.